Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × X-Ray Therapy × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cyclophosphamide 363 Radiotherapy 237 fludarabine 205 Gemcitabine 180 Cisplatin 177 pembrolizumab 161 Nivolumab 161 Paclitaxel 154 Carboplatin 142 Magnetic Resonance Spectroscopy 139 fludarabine phosphate 136 Bevacizumab 113 Irinotecan 112 Cytarabine 110 Temozolomide 109 Capecitabine 105 Specimen Handling 104 Radiosurgery 104 Radiation 100 Docetaxel 100 Biopsy 95 Etoposide 94 Dexamethasone 94 Ipilimumab 92 Fluorouracil 91 Rituximab 90 Oxaliplatin 88 Filgrastim 86 Sorafenib 85 Lenalidomide 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02064036 2022-10-18

CCRO025

University of California, Davis

Phase 1 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡